|
Familial dysautonomia, or FD, is a disorder of the autonomic nervous system which affects the development and survival of sensory, sympathetic and some parasympathetic neurons in the autonomic and sensory nervous system resulting in variable symptoms including: insensitivity to pain, inability to produce tears, poor growth, and labile blood pressure (episodic hypertension and postural hypotension). People with FD have frequent vomiting crises, pneumonia, problems with speech and movement, difficulty swallowing, inappropriate perception of heat, pain, and taste, as well as unstable blood pressure and gastrointestinal dysmotility. FD does not affect intelligence. Originally reported by Riley, et al. in 1949, FD is one example of a group of disorders known as hereditary sensory and autonomic neuropathies HSAN. All HSAN are characterized by widespread sensory dysfunction and variable autonomic dysfunction caused by incomplete development of sensory and autonomic neurons. The disorders are believed to be genetically distinct from each other. Image File history File links No higher resolution available. ...
It has been suggested that this article or section be merged into Dominance relationship. ...
The International Statistical Classification of Diseases and Related Health Problems (most commonly known by the abbreviation ICD) provides codes to classify diseases and a wide variety of signs, symptoms, abnormal findings, complaints, social circumstances and external causes of injury or disease. ...
The following codes are used with International Statistical Classification of Diseases and Related Health Problems. ...
// G00-G99 - Diseases of the nervous system (G00-G09) Inflammatory diseases of the central nervous system (G00) Bacterial meningitis, not elsewhere classified (G01) Meningitis in bacterial diseases classified elsewhere (G02) Meningitis in other infectious and parasitic diseases classified elsewhere (G03) Meningitis due to other and unspecified causes (G04) Encephalitis, myelitis...
The International Statistical Classification of Diseases and Related Health Problems (most commonly known by the abbreviation ICD) provides codes to classify diseases and a wide variety of signs, symptoms, abnormal findings, complaints, social circumstances and external causes of injury or disease. ...
The following is a list of codes for International Statistical Classification of Diseases and Related Health Problems. ...
The Mendelian Inheritance in Man project is a database that catalogues all the known diseases with a genetic component, and - when possible - links them to the relevant genes in the human genome. ...
The Disease Bold textDatabase is a free website that provides information about the relationships between medical conditions, symptoms, and medications. ...
eMedicine is an online clinical medical knowledge base that was founded in 1996. ...
Medical Subject Headings (MeSH) is a huge controlled vocabulary (or metadata system) for the purpose of indexing journal articles and books in the life sciences. ...
This article or section is in need of attention from an expert on the subject. ...
Neurons (also called nerve cells) are the primary cells of the nervous system. ...
The Human Nervous System The nervous system of an animal coordinates the activity of the muscles, monitors the organs, constructs and also stops input from the senses, and initiates actions. ...
Hereditary Sensory and Autonomic Neuropathy is a condition used to describe one of seven diseases which prevents one from feeling actual pain although they can feel other sensations through touch. ...
Incidence
FD is seen almost exclusively in Ashkenazi Jews and is inherited in an autosomal recessive fashion. Both parents must be carriers in order for a child to be affected. The carrier frequency in Jewish individuals of Eastern European (Ashkenazi) ancestry is about 1/30, while the carrier frequency in non-Jewish individuals is about 1/3000. If both parents are carriers, there is a one in four, or 25%, chance with each pregnancy for an affected child. Genetic counseling and genetic testing is recommended for families who may be carriers of familial dysautonomia. Ashkenazi Jews, also known as Ashkenazic Jews or Ashkenazim (×ַש×Ö°×Ö¼Ö²× Ö¸×Ö´× ×ַש×Ö°×Ö¼Ö²× Ö¸×Ö´×× Standard Hebrew, AÅ¡kanazi,AÅ¡kanazim, Tiberian Hebrew, ʾAÅ¡kÄnÄzî, ʾAÅ¡kÄnÄzîm, pronounced sing. ...
In genetics, the term recessive gene refers to an allele that causes a phenotype (visible or detectable characteristic) that is only seen in a homozygous genotype (an organism that has two copies of the same allele). ...
Genetic counseling is the process by which patients or relatives, at risk of an inherited disorder, are advised of the consequences and nature of the disorder, the probability of developing or transmitting it, and the options open to them in management and family planning in order to prevent, avoid or...
Genetic testing allows the genetic diagnosis of vulnerabilities to inherited diseases, and can also be used to determine a persons ancestry. ...
There have been 590 cases in total. Currently there are 350 people living with this condition worldwide.
Etiology Familial Dysautonomia, is the result of mutations in IKBKAP gene on chromosome 9, which encodes for the IKAP protein (IkB kinase complex associated protein). There have been three mutations in IKBKAP identified in individuals with FD. The most common FD-causing mutation occurs in intron 20 of the donor gene. Conversion of T-->C in intron 20 of the donor gene resulted in shift splicing that generates an IKAP transcript lacking exon 20. Translation of this mRNA results in a truncated protein lacking all of the amino acids encoded in exons 20-37. Another less common mutation is a G-->C conversion resulting in one amino acid mutation in 696, where Proline substitutes normal Arginine. The decreased amount of functional IKAP protein in cells causes Familial Dysautonomia. IKBKAP (inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein) is a human gene that provides instructions to make the IKAP protein, which is found in a variety of cells throughout the body, including brain cells. ...
Chromosome 9 is one of the 23 pairs of chromosomes in humans. ...
Diagram of the location of introns and exons within a gene. ...
An exon is any region of DNA within a gene, that is transcribed to the final messenger RNA (mRNA) molecule, rather than being spliced out from the transcribed RNA molecule. ...
L-Proline is one of the twenty proteinogenic units which are used in living organisms as the building blocks of proteins. ...
Arginine (symbol Arg or R) is an α-amino acid. ...
Diagnosis Symptoms Symptoms displayed by a baby with FD might include: - The most distinctive clinical feature is absence of overflow tears with emotional crying after age 7 months.
- High prevalence of breech presentation
- Weak or absent suck and poor tone
- Poor suck and misdirected swallowing
- Red blotching of skin
Symptoms in an older child with FD might include: - Delayed speech and walking
- Unsteady gait
- Spinal curvature
- Corneal abrasion
- Less perception in pain or temperature with nervous system.
- Poor growth
- Erratic or unstable blood pressure.
- Red puffy hands
- Dysautonomia crisis: constellation of symptoms response to physical and emotional stress; usually accompanied by vomiting, increased heart rate, increase in blood pressure, sweating, drooling, blotching of the skin and a negative change in personality.
Corneal abrasion is a medical condition involving the loss of the surface epithelial layer of the eyes cornea. ...
The Human Nervous System The nervous system of an animal coordinates the activity of the muscles, monitors the organs, constructs and also stops input from the senses, and initiates actions. ...
A sphygmomanometer, a device used for measuring blood pressure. ...
Vomiting (also throwing up or emesis) is the forceful expulsion of the contents of ones stomach through the mouth and sometimes the nose. ...
A sphygmomanometer, a device used for measuring blood pressure. ...
Sweat redirects here. ...
Drooling (also known as ptyalism) is when saliva flows outside the mouth. ...
Clinical Diagnosis A clinical diagnosis of FD is supported by a constellation of criteria: - Parents of Ashkenazi Jewish Background
- No fungiform papillae on the tongue
- Decreased deep tendon reflexes
- Lack of an axon flare following intradermal histamine
- No overflow tears with emotional crying
Ashkenazi Jews, also known as Ashkenazic Jews or Ashkenazim (×ַש×Ö°×Ö¼Ö²× Ö¸×Ö´× ×ַש×Ö°×Ö¼Ö²× Ö¸×Ö´×× Standard Hebrew, AÅ¡kanazi,AÅ¡kanazim, Tiberian Hebrew, ʾAÅ¡kÄnÄzî, ʾAÅ¡kÄnÄzîm, pronounced sing. ...
Genetic Testing Genetic testing is performed on a small sample of blood from the tested individual. The DNA is examined with a designed probe specific to the known mutations. The accuracy of the test is above 99%. The structure of part of a DNA double helix Deoxyribonucleic acid (DNA) is a nucleic acid that contains the genetic instructions for the development and function of living organisms. ...
Prenatal Testing Familial Dysautonomia is inherited in an autosomal recessive pattern, which means 2 copies of the gene in each cell are altered. If both parents are shown to be carriers by generic testing, there is a 25% chance that the child will produce FD. Prenatal diagnosis for pregnancies at increased risk for FD by amniocentesis (for 14-17 weeks) or chorionic villus sampling (for 10-11 weeks) is possible. In genetics, the term recessive gene refers to an allele that causes a phenotype (visible or detectable characteristic) that is only seen in a homozygous genotype (an organism that has two copies of the same allele). ...
Amniocentesis, or an Amniotic Fluid Test (AFT), is a medical procedure used for prenatal diagnosis, in which a small amount of amniotic fluid is extracted from the amnion around a developing fetus. ...
Chorionic villus sampling (CVS) is a form of prenatal diagnosis to determine genetic abnormalities in the fetus. ...
Treatment and Treatment Locations There currently is no cure for FD and death occurs in 50% of affected individuals by age 30. There are only two treatment centers One at New York University Hospital Dysautonomia Treatment and Evaluation Center and one at the Hadassah Hospital Familial Dysautonomia Center. One is being planned for the San Francisco area Forward Article The survival rate and quality of life has increased since the mid 80's mostly due to greater understanding of the most dangerous symptoms. At present, FD patients can be expected to function independently if treatment is begun early and major disabilities avoided. A major issue has been Aspiration Pneumonias, where food or regurgitated stomach content would be aspirated into the lungs causing infections. Fundoplacations (by preventing regurgitation) and gastrostomy tubes (to provide non oral nutrition) have reduced the frequency of hospitalization. Nissen fundoplication is a surgical procedure to treat gastroesophageal reflux disease (GERD) and hiatus hernia. ...
Other issues which can be treated include FD Crises, Scoliosis, and various eye conditions due to limited or no tears. An FD crisis is the body's loss of control of various Autonomic nervous system functions including blood pressure, heartrate, and body temperature. Both short term and chronic periodic high or low blood pressure have consequences and medication is used to stabilize blood pressure. This article or section is in need of attention from an expert on the subject. ...
Treatment of Manifestations Although the FD-causing gene has been identifies and it seems to have tissue specific expression, there is no definitive treatment at present. Treatment of FD remains preventative, symptomatic and supportive. FD does not express itself in a consistent manner. The type and severity of symptoms displayed vary among patients and even at different ages on the same patients. So patients should have specialized individual treatment plans. Medications are used to control vomiting, eye dryness, and blood pressure. There are some commonly needed treatments including: A sphygmomanometer, a device used for measuring blood pressure. ...
- Artificial tears: using eye drop containing artificial tear solutions (methylcellulose)
- Feeding: Maintenance of adequate nutrition, avoidance of aspiration; thickened formula and different shaped nipples are used for baby.
- Daily chest physiotherapy (nebulization, bronchodilators, and posural drainage): for Chronic lung disease from recurrent aspiration pneumonia
- Special drug management of autonomic manifestations such as vomiting: intravenous or rectal diazepam (0.2 mg/kg q3h) and rectal chloral hydrate (30 mg/kg q6h)
- Protecting the child from injury (coping with decreased taste, temperature and pain perception)
- Combating orthostatic hypotension: hydration, leg exercise, frequent small meals, a high-salt diet, and drugs such as fludrocortisone.
- Treatment of orthopedic problems (tibial torsion and spinal curvature)
- Compensating for labile blood pressures
Physical therapy can help restore lost functionality in many people. ...
Wikipedia does not yet have an article with this exact name. ...
Pneumonia is an illness of the lungs and respiratory system in which the alveoli (microscopic air-filled sacs of the lung responsible for absorbing oxygen from the atmosphere) become inflamed and flooded with fluid. ...
Diazepam (IPA: ), marketed under brand names Valium, Stesolid, Diazemuls, Seduxen, Bosaurin, Diapam, Antenex, Ducene and Apozepam)[1] is a drug which is a benzodiazepine derivative. ...
Orthostatic hypotension (also known as postural hypotension and, colloquially, as head rush) is a sudden fall in blood pressure, typically greater than 20/10 mm Hg, that occurs when a person assumes a standing position. ...
Fludrocortisone acetate is a synthetic corticosteroid with moderate glucocorticoid potency and much greater mineralocorticoid potency. ...
Therapies under investigation It is noted that in cell lines derived from heterozygous carriers of FD who display a normal phenotype, there are decreased levels of the wild-type IKAP transcript and also functional IKAP protein respectively. This would suggest that increasing the amount of the wild-type IKAP transcript may improve the manifestation in patients with FD. Application of tocotrienols in the treatment of FD was initiated in the FD research lab at Fordham University in Bronx. In vitro supplementation of tocotrienols elevated the expression of IKAP transcripts as well as the amount of induced functional IKAP protein in homozygous cell lines derived from FD patients. This observed result further suggests the value of therapeutic approaches to lessen suffered symptoms of FD patients by elevating cellular level of functional IKAP which can be induced by tocotrienols. Heterozygote cells are diploid or polyploid and have different alleles at a locus (position) on homologous chromosomes. ...
Chemical structure of Tocotrienol Tocotrienols â Together with Tocopherols, compose the vitamin E family. ...
Chemical structure of Tocotrienol Tocotrienols â Together with Tocopherols, compose the vitamin E family. ...
Homozygote cells are diploid or polyploid and have the same alleles at a locus (position) on homologous chromosomes. ...
Chemical structure of Tocotrienol Tocotrienols â Together with Tocopherols, compose the vitamin E family. ...
One form of therapy under investigation is electrolyte therapy for refractory seizures common among FD carriers. See Ceralyte[1] An electrolyte is a substance containing free ions which behaves as an electrically conductive medium. ...
Manufactured by Cera Products Inc, CeraLyte is a rice-based oral rehydration solution (ORS) for diarrhea and dehydration. ...
Prognosis The outlook for patients with FD depends on the particular diagnostic category. Patients with chronic, progressive, generalized dysautonomia in the setting of central nervous system degeneration have a generally poor long-term prognosis. Death can occur from pneumonia, acute respiratory failure, or sudden cardiopulmonary arrest in such patients. Educate parents and patients regarding daily eye care and early warning signs of corneal problems as well as use of punctual cautery. This education has resulted in decreased corneal scarring and need for more aggressive surgical measures such as tarsorrhaphy, conjunctival flaps, and corneal transplants. Dysautonomia is any disease or malfunction of the autonomic nervous system. ...
Prognosis (older Greek ÏÏÏγνÏÏιÏ, modern Greek ÏÏÏγνÏÏη - literally fore-knowing, foreseeing) is a medical term denoting the doctors prediction of how a patients disease will progress, and whether there is chance of recovery. ...
Pneumonia is an illness of the lungs and respiratory system in which the alveoli (microscopic air-filled sacs of the lung responsible for absorbing oxygen from the atmosphere) become inflamed and flooded with fluid. ...
Tarsorrhaphy is a surgical procedure in which the eyelids are partially sewn together to narrow the opening. ...
Cornea Transplant A cornea transplant, also known as a corneal graft or penetrating keratoplasty, is a surgical procedure where a damaged or diseased cornea is replaced by a donor. ...
The Future In January of 2001, researchers at Massachusetts General Hospital isolated the FD gene, a discovery that opens the door to many diagnostic and treatment possibilities. Massachusetts General Hospital (often abbreviated to Mass General or just MGH) is a teaching hospital of Harvard Medical School and biomedical research facility in Boston, Massachusetts. ...
Although it probably won't happen for five or 10 years, some expect that stem-cell therapy will result. Eventually, treatment could be given in utero. While that may be years ahead, genetic screening became available around April 2001, enabling Ashkenazi Jews to find out if they are carriers. In the mean time more research into treatments are being funded by the foundations that exist. These foundation are organized and run by parents of those with FD. There is very limited governmental support beyond recognizing those diagnosed with FD as eligible for certain programs.
References - Anderson SL, Coli R, Daly IW, Kichula EA, Rork MJ, Volpi SA, Ekstein J, Rubin BY (2001). "Familial dysautonomia is caused by mutations of the IKAP gene". Am J Hum Genet 68 (3): 753-8. PMID 11179021.
- Axelrod FB, Hilz MJ (2003). "Inherited autonomic neuropathies". Semin Neurol 23 (4): 381-90. PMID 15088259.
- Axelrod FB (2004). "Familial dysautonomia". Muscle Nerve 29 (3): 352-63. PMID 14981733.
- Axelrod FB (2002). "Hereditary sensory and autonomic neuropathies. Familial dysautonomia and other HSANs". Clin Auton Res 12 Suppl 1: I2-14. PMID 12102459.
- Slaugenhaupt SA, Blumenfeld A, Gill SP, Leyne M, Mull J, Cuajungco MP, Liebert CB, Chadwick B, Idelson M, Reznik L, Robbins C, Makalowska I, Brownstein M, Krappmann D, Scheidereit C, Maayan C, Axelrod FB, Gusella JF (2001). "Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia". Am J Hum Genet 68 (3): 598-605. PMID 11179008.
- Slaugenhaupt SA, Gusella JF (2002). "Familial dysautonomia". Curr Opin Genet Dev 12 (3): 307-11. PMID 12076674.
- Axelrod FB, Nachtigal R, Dancis J (1974). "Familial dysautonomia: diagnosis, pathogenesis and management". Adv Pediatr 21: 75-96. PMID: 4217094.
- Brunt PW, McKusick VA. (1970 September). "Familial dysautonomia. A report of genetic and clinical studies, with a review of the literature". Medicine (Baltimore) 49 (5): 343-74. PMID: 4322121.
- Riley CM, Day RL, Greely D, Langford WS (1949). "Central autonomic dysfunction with defective lacrimation". Pediatrics 3: 468-77.
- Axelrod FB (1996). "Familial Dysautonomia". Robertson D, Low PA, Polinsky RJ (Eds.), Primer on the Autonomic Nervous System, Academic Press, San Diego: 242-9.
- Anderson SL, Qiu J, and Rubin BY (2003). "Tocotrienols induce IKBKAP expression: a possible therapy for Familial Dysautonomia.". Biochem. Biophys. Res. Commun. 306: 303-309. PMID: 12788105.
- Anderson SL, Rubin BY. "Tocotrienols reverse IKAP and monoamine oxidase deficiencies in familial dysautonomia.". Biochem. Biophys. Res. Commun 336: 150-156. PMID: 16125677.
Footnotes - ^ Ochoa, Juan G. MD (2004). "Electrolyte Therapy for Refractory Seizures in Familial Dysautonomia". Epilepsia 45: 1461-1462.
See also Congenital insensitivity to pain (or congenital analgia) is a rare condition where a child cannot feel (and has never felt) physical pain. ...
Hereditary Sensory and Autonomic Neuropathy is a disease which prevents one from feeling actual pain although they can feel other sensations through touch. ...
External links | Nervous system pathology (G) | | Inflammatory diseases of the central nervous system | Meningitis - Encephalitis - Myelitis - Encephalomyelitis (Acute disseminated) - Tropical spastic paraparesis | | Systemic atrophies primarily affecting the central nervous system | Huntington's disease - Spinocerebellar ataxia (Friedreich's ataxia, Ataxia telangiectasia, Hereditary spastic paraplegia) - Spinal muscular atrophy (Werdnig-Hoffman disease, Fazio Londe syndrome, Kugelberg-Welander disease, Motor neurone disease, Amyotrophic lateral sclerosis, Primary lateral sclerosis, Progressive bulbar palsy) | | Extrapyramidal and movement disorders | Parkinson's disease - Neuroleptic malignant syndrome - Postencephalitic parkinsonism - Progressive supranuclear palsy - Striatonigral degeneration - Dystonia (Spasmodic torticollis, Meige's syndrome, Blepharospasm) - Essential tremor - Myoclonus - Restless legs syndrome - Stiff person syndrome - Alzheimer's disease - Multiple sclerosis - Central pontine myelinolysis | | Episodic and paroxysmal disorders | Seizure/Epilepsy (Focal seizures, Complex partial seizure, Absence seizure, Atonic seizure, Lennox-Gastaut syndrome, West syndrome, Epilepsia partialis continua, Status epilepticus) - Headache (Migraine, Cluster, Vascular, Tension) - Amaurosis fugax - Foville's syndrome - Millard-Gubler syndrome - Lateral medullary syndrome - Weber's syndrome - Sleep disorder (Insomnia, Hypersomnia, Sleep apnea, Narcolepsy, Cataplexy) | | Nerve, nerve root and plexus disorders | Trigeminal neuralgia - Bell's palsy - Thoracic outlet syndrome - Phantom limb - Mononeuropathy (Carpal tunnel syndrome, Meralgia paraesthetica, Tarsal tunnel syndrome) | | Polyneuropathies and other disorders of the peripheral nervous system | Charcot-Marie-Tooth disease - Dejerine Sottas syndrome - Refsum's disease - Morvan's syndrome - Guillain-Barré syndrome - Polyneuropathy - Alcoholic polyneuropathy | | Diseases of myoneural junction and muscle | Myasthenia gravis - Muscular dystrophy - Myotonic dystrophy - Myotonia congenita - Thomsen disease - Neuromyotonia - Paramyotonia congenita - Centronuclear myopathy - Periodic paralysis (Hypokalemic, Hyperkalemic) - Lambert-Eaton myasthenic syndrome | | Cerebral palsy and other paralytic syndromes | Cerebral palsy - Paralysis - Hemiplegia - Spastic paraplegia - Paraplegia - Quadriplegia - Diplegia - Monoplegia - Cauda equina syndrome | | Other disorders of the nervous system | autonomic (Peripheral neuropathy, Familial dysautonomia, Horner's syndrome, Multiple system atrophy, Shy-Drager syndrome) - Hydrocephalus (Normal pressure) - Idiopathic intracranial hypertension - Encephalopathy - Brain herniation - Cerebral edema - Reye's syndrome - Syringomyelia - Syringobulbia - Spinal cord compression | |